SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-107173
Filing Date
2020-09-22
Accepted
2020-09-22 07:30:56
Documents
3
Period of Report
2020-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2028947-4_8k.htm 8-K 26961
2 EXHIBIT 99.1 tm2028947d4_ex99-1.htm EX-99.1 10724
3 GRAPHIC tm2028947d4_ex99-1img001.jpg GRAPHIC 4261
  Complete submission text file 0001104659-20-107173.txt   44993
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 201187862
SIC: 2834 Pharmaceutical Preparations